Cyclica, Inc.

With a population one-tenth the size of the US, Canada often sits in the shadow of its neighbour to the south. But when it comes to the quality of its life sciences research and biotech innovation, it

The contraceptive market is one famously defined by its lack of innovation. Despite pioneering attempts by researchers to bring new contraceptive options to market – particularly efforts to develop a

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kelun, Merck Ink Third Cancer Coll

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly/Innovent Deal Follows FDA’s Rejec